FAM123B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.35453886890491E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.98423566045403E-13 |
Normal-vs-Stage2 |
2.46239999501796E-08 |
Normal-vs-Stage3 |
4.20040002779842E-09 |
Normal-vs-Stage4 |
4.27070045994071E-10 |
Stage1-vs-Stage2 |
3.663400E-01 |
Stage1-vs-Stage3 |
1.981550E-01 |
Stage1-vs-Stage4 |
1.561600E-01 |
Stage2-vs-Stage3 |
7.077000E-01 |
Stage2-vs-Stage4 |
8.009200E-01 |
Stage3-vs-Stage4 |
8.756600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37240227463076E-11 |
Normal-vs-AfricanAmerican |
3.90720789056331E-12 |
Normal-vs-Asian |
2.282600E-01 |
Caucasian-vs-AfricanAmerican |
3.224100E-02 |
Caucasian-vs-Asian |
2.089200E-01 |
AfricanAmerican-vs-Asian |
2.434000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.67479396806903E-12 |
Normal-vs-Female |
1.68864922045486E-12 |
Male-vs-Female |
6.741600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.52710000200784E-08 |
Normal-vs-Age(41-60Yrs) |
4.3998005239132E-10 |
Normal-vs-Age(61-80Yrs) |
1.62503344114384E-12 |
Normal-vs-Age(81-100Yrs) |
2.186300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.182800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.578000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.673200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.642800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.832800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.627400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.383800E-02 |
Normal-vs-Grade 2 |
9.96924764962159E-12 |
Normal-vs-Grade 3 |
9.0569773902871E-12 |
Normal-vs-Grade 4 |
7.11910530526438E-11 |
Grade 1-vs-Grade 2 |
1.449410E-01 |
Grade 1-vs-Grade 3 |
1.300360E-01 |
Grade 1-vs-Grade 4 |
3.434200E-02 |
Grade 2-vs-Grade 3 |
1.248610E-01 |
Grade 2-vs-Grade 4 |
3.532000E-02 |
Grade 3-vs-Grade 4 |
4.331600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.38640013200597E-10 |
Normal-vs-ccB subtype |
5.76380054795322E-11 |
ccA subtype-vs-ccB subtype |
2.048000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.3002999505195E-10 |
Normal-vs-N1 |
1.94567999999284E-05 |
N0-vs-N1 |
3.303600E-01 |
|
|